线粒体DNA拷贝数与卒中后/短暂性脑缺血发作结局的亚型特异性关联:中国10241例患者分析
基于第三次中国国家卒中登记的前瞻性观察队列,纳入10241例缺血性卒中或短暂性脑缺血发作患者,分析线粒体DNA拷贝数与12个月随访结局的关联。结果显示,较低线粒体DNA拷贝数与≤65岁患者12个月卒中复发及3个月全因死亡相关,且复发关联特定于不明原因型卒中,功能结局关联特定于不明原因型卒中中诊断为栓塞性卒中不明来源的患者。
要点
- 较低线粒体DNA拷贝数与≤65岁患者12个月卒中复发(亚分布风险比1.15/SD降低)及3个月全因死亡(风险比2.19)相关。
- 线粒体DNA拷贝数与卒中复发的关联特定于不明原因型卒中(亚分布风险比1.28)。
- 较低线粒体DNA拷贝与不明原因型卒中中栓塞性卒中不明来源患者较差功能结局相关(比值比1.53)。
核心结论
- 较低线粒体DNA拷贝数与不明原因型卒中、栓塞性卒中不明来源及年轻患者随访期间更高的卒中复发率、全因死亡率和较差功能结局相关。
研究设计与样本
- 基于第三次中国国家卒中登记的前瞻性观察队列分析,纳入10241例有全基因组测序数据的缺血性卒中或短暂性脑缺血发作患者(平均年龄62.2岁,标准差11.2;男性68.8%)。
主要发现
- 在≤65岁患者中,线粒体DNA拷贝数每降低1个标准差,12个月卒中复发亚分布风险比为1.15(95% CI 1.04-1.27;P=5.2×10-3),3个月全因死亡风险比为2.19(95% CI 1.41-3.39;P=5.0×10-4)。
- 在不明原因型卒中患者中,线粒体DNA拷贝数每降低1个标准差,卒中复发亚分布风险比为1.28(95% CI 1.11-1.48;P=6.6×10-4)。
- 在不明原因型卒中中诊断为栓塞性卒中不明来源的患者中,较低线粒体DNA拷贝数与较差功能结局相关,比值比为1.53(95% CI 1.20-1.94;P=5.4×10-4),排除复发性卒中患者后仍显著(比值比1.49 [95% CI 1.14-1.94];P=3.0×10-3)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mitochondrial DNA copy number (mtDNA-CN) is associated with the severity and mortality in patients with stroke, but the associations in different stroke subtypes remain unexplored. METHODS: We conducted an observational prospective cohort analysis on patients with ischemic stroke or transient ischemic attack enrolled in the Third China National Stroke Registry. We applied logistic models to assess the association of mtDNA-CN with functional outcome (modified Rankin Scale score, 3-6 versus 0-2) and Cox proportional hazard models to assess the association with stroke recurrence (treating mortality as a competing risk) and mortality during a 12-month follow-up, adjusting for sex, age, physical activity, National Institutes of Health Stroke Scale at admission, history of stroke and peripheral artery disease, small artery occlusion, and interleukin-6. Subgroup analyses stratified by age and stroke subtypes were conducted. RESULTS: The Third China National Stroke Registry enrolled 15 166 patients, of which 10 241 with whole-genome sequencing data were retained (mean age, 62.2 [SD, 11.2] years; 68.8% men). The associations between mtDNA-CN and poststroke/transient ischemic attack outcomes were specific to patients aged ≤65 years, with lower mtDNA-CN significantly associated with stroke recurrence in 12 months (subdistribution hazard ratio, 1.15 per SD lower mtDNA-CN [95% CI, 1.04-1.27]; P=5.2×10-3) and higher all-cause mortality in 3 months (hazard ratio, 2.19 [95% CI, 1.41-3.39]; P=5.0×10-4). Across subtypes, the associations of mtDNA-CN with stroke recurrence were specific to stroke of undetermined cause (subdistribution hazard ratio, 1.28 [95% CI, 1.11-1.48]; P=6.6×10-4). In particular, lower mtDNA-CN was associated with poorer functional outcomes in stroke of undetermined cause patients diagnosed with embolic stroke of undetermined source (odds ratio, 1.53 [95% CI, 1.20-1.94]; P=5.4×10-4), which remained significant after excluding patients with recurrent stroke (odds ratio, 1.49 [95% CI, 1.14-1.94]; P=3.0×10-3). CONCLUSIONS: Lower mtDNA-CN is associated with higher stroke recurrence rate and all-cause mortality, as well as poorer functional outcome at follow-up, among stroke of undetermined cause, embolic stroke of undetermined source, and younger patients.
引用
- Jiang Y, Cheng S, Shi Y, et al. Subtype-Specific Association of Mitochondrial DNA Copy Number With Poststroke/TIA Outcomes in 10 241 Patients in China. Stroke. 2024. PMID: 38511332. doi:10.1161/STROKEAHA.123.045069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。